Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Shelter Pharma Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹39.20 |
|---|---|
| Day's Range | ₹38.00 - ₹41.20 |
| Open | ₹41.19 |
| 52 Week Range | ₹23.00 - ₹46.51 |
| Volume | 1,08,000 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 42.34 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 6.76 |
| TTM EPS (₹) | 5.36 |
| P/E Ratio | 5.78 |
| Book Value(₹) | 1.01 |
| PAT Margin (%) | 14.29 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 25.07 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 506.6 |
| Expenses | N/A | N/A |
| PBT | N/A | 96.77 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | 72.37 |
About Shelter Pharma Ltd.
| Founded | 2007 |
|---|---|
| Managing Director | Mustaqim Nisarahmed Sabugar |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,34,279.63 | 1,782.00 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 2,46,737.12 | 9,212.85 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,81,129.27 | 4,755.15 | 3,480.60 - 3,480.60 |
| Lenskart Solutions Ltd. | 1,20,264.32 | 686.35 | 0.00 - 0.00 |
| Apollo Hospitals Enterprise Ltd. | 1,16,695.63 | 8,010.00 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,14,239.13 | 1,138.50 | 835.50 - 835.50 |
| Cipla Ltd. | 1,08,808.05 | 1,334.00 | 1,165.70 - 1,165.70 |
| Laurus Labs Ltd. | 1,07,468.10 | 1,964.00 | 843.00 - 843.00 |
| Mankind Pharma Ltd. | 1,04,376.49 | 2,479.95 | 1,909.70 - 1,909.70 |
| Dr. Reddy's Laboratories Ltd. | 1,00,169.98 | 1,208.00 | 1,101.00 - 1,101.00 |
No Records Found
Latest News
Sep
23
2026
Posted on Sep 23rd 2026
Shelter Pharma informs about doctor’s review and feedback on products
Pursuant to Regulation 30, read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shelter Pharma has informed that the company received positive feedback from well-known Doctor C.M. Patel regarding its products. Dr. C. M. Patel shared a review of the Company’s products through social media, highlighting their effective results, unique formulation, 100% natural composition, and benefits in supporting the overall growth and development of children. The feedback relates to the Company’s products in the Human Healthcare segment, namely Lemonade Barley Water, Alkaliser syrup, Joemega capsules. This feedback reflects that the Company's products are gaining acceptance even within the medical professionals and its continued focus on quality, safety and reliability across its human healthcare portfolio. It further reaffirms the Company's commitment to ethical business practices and the confidence reposed in it by healthcare professionals and consumers. This development further strengthens company’s growing presence and credibility in the healthcare industry.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
7
2026
Posted on Sep 7th 2026
Shelter Pharma informs about press release
Shelter Pharma has informed that it enclosed copies of Newspaper Publications dated 06th September, 2026, in respect of information regarding 19th Annual General Meeting of the Company scheduled on Tuesday, 29th September, 2026 at 11:00 AM IST at Registered office of the Company at Shelternagar, Nr. Bus Station, Himatnagar-383001 Gujarat, India: Financial Express (English); Gujarat Samachar (Gujarati). It enclosed the extract of notice published in the aforesaid newspapers. The above advertisement will be made available at the website at https://shelter.co.in.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
24
2026
Posted on Aug 24th 2026
Shelter Pharma informs about completion and commencement of dispatch of export order
Pursuant to Regulation 30 read with schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shelter Pharma has informed that the Company has successfully completed the manufacturing of the export purchase order received from Taha Drugs & Chemicals Co for the supply of Joemega Capsule aggregating 1,44,000 $. They further informed that the aforesaid amount has been fully settled and the said order has been dispatched to Sudan. The Management of Shelter Pharma has informed that the export order to Sudan has been successfully completed and delivered, thus setting yet another milestone in the growth journey of the Company. This success highlights the growing international presence of the Company along with its dedication towards prompt delivery of high-quality products to its customers around the globe. This success is a clear reflection of the modern manufacturing facility, stringent quality control systems and hard work of the team of experts at the Company. The success of the order once again highlights the commitment of the Company towards ethical business practices as well as the trust reposed in the Company by international stakeholders. As a growing name in the field of Pharmaceutical and Nutraceuticals, the Company continues to be committed towards innovation and quality in all its products.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
31
2026
Posted on Jul 31st 2026
Shelter Pharma informs about outcome of board meeting
Shelter Pharma has informed that Board of Directors of the Company at its meeting held today, Friday, 31st July, 2026 has discussed, approved, and taken on record the following matters attached.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
31
2026
Posted on Jul 31st 2026
Shelter Pharma informs about appointment of director
Shelter Pharma has informed that Board of Directors of the Company at its meeting held today, Friday, 31st July, 2026 approved appointment of Vinita Shivraj Gadhvi as an Additional Independent Director pursuant to the provisions of Sections 149, 152, and 161(1) read with Schedule IV of the Companies Act, 2013, and based on the recommendation of the Nomination and Remuneration Committee. Her tenure is fixed for a period of five consecutive years with effect from 31st July, 2026, subject to the approval of the shareholders of the Company during which she will not be liable to retire by rotation. The aforesaid Director are not related to any Director or Key Managerial Personnel on the Board of the Company. Further the Director is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority.
The above information is a part of company’s filings submitted to BSE.
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Shelter Pharma Ltd. is ₹39.20 as of 2026-10-05.
The market capitalisation of Shelter Pharma Ltd. is ₹61.03 as of 2026-10-01.
The 1-year return of Shelter Pharma Ltd. is -5.30% as of 2025-10-03.
The P/E ratio of Shelter Pharma Ltd. is 5.78 as of 2026-10-05.
The 52-week high and low of Shelter Pharma Ltd. are ₹46.51 and ₹23.00, respectively, as of 2026-10-05.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
